Q Biomed Inc (QBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 11/30
(Values in U.S. thousands)
| 11-2022 | 11-2021 | 11-2020 | 11-2019 | 11-2018 | |
| Sales | 284 | 196 | 30 | 0 | 0 |
| Cost of Goods | 293 | 247 | 326 | N/A | N/A |
| Gross Profit | -9 | -51 | -296 | N/A | N/A |
| Operating Expenses | 3,730 | 7,584 | 13,175 | 8,020 | 9,020 |
| Operating Income | -3,446 | -7,389 | -13,145 | -8,020 | -9,020 |
| Interest Expense | 1,385 | 507 | 296 | 1,460 | 162 |
| Other Income | 2,778 | -345 | -51 | -799 | -89 |
| Pre-tax Income | -2,052 | -8,241 | -13,492 | -10,280 | -9,271 |
| Net Income Continuous | -2,052 | -8,241 | -13,492 | -10,280 | -9,271 |
| Net Income | $-2,052 | $-8,241 | $-13,492 | $-10,280 | $-9,271 |
| EPS Basic Total Ops | -0.08 | -0.33 | -0.65 | -0.68 | -0.67 |
| EPS Basic Continuous Ops | -0.05 | -0.31 | -0.61 | -0.68 | -0.68 |
| EPS Diluted Total Ops | -0.08 | -0.33 | -0.65 | -0.68 | -0.67 |
| EPS Diluted Continuous Ops | -0.05 | -0.31 | -0.61 | -0.68 | -0.68 |
| EPS Diluted Before Non-Recurring Items | -0.08 | -0.33 | N/A | -0.68 | -0.67 |
| EBITDA(a) | $-2,473 | $-6,931 | $-12,957 | $-6,969 | $-8,887 |